These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30214939)

  • 1. Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.
    Gast CE; Silk AD; Zarour L; Riegler L; Burkhart JG; Gustafson KT; Parappilly MS; Roh-Johnson M; Goodman JR; Olson B; Schmidt M; Swain JR; Davies PS; Shasthri V; Iizuka S; Flynn P; Watson S; Korkola J; Courtneidge SA; Fischer JM; Jaboin J; Billingsley KG; Lopez CD; Burchard J; Gray J; Coussens LM; Sheppard BC; Wong MH
    Sci Adv; 2018 Sep; 4(9):eaat7828. PubMed ID: 30214939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.
    Dietz MS; Sutton TL; Walker BS; Gast CE; Zarour L; Sengupta SK; Swain JR; Eng J; Parappilly M; Limbach K; Sattler A; Burlingame E; Chin Y; Gower A; Mira JLM; Sapre A; Chiu YJ; Clayburgh DR; Pommier SJ; Cetnar JP; Fischer JM; Jaboin JJ; Pommier RF; Sheppard BC; Tsikitis VL; Skalet AH; Mayo SC; Lopez CD; Gray JW; Mills GB; Mitri Z; Chang YH; Chin K; Wong MH
    Sci Rep; 2021 Jul; 11(1):13630. PubMed ID: 34211050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.
    Soeth E; Grigoleit U; Moellmann B; Röder C; Schniewind B; Kremer B; Kalthoff H; Vogel I
    J Cancer Res Clin Oncol; 2005 Oct; 131(10):669-76. PubMed ID: 16136352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of Pancreatic Cancer.
    Dimastromatteo J; Houghton JL; Lewis JS; Kelly KA
    Cancer J; 2015; 21(3):188-93. PubMed ID: 26049698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.
    Feng H; Ou BC; Zhao JK; Yin S; Lu AG; Oechsle E; Thasler WE
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1771-1786. PubMed ID: 28497169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
    Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
    Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients.
    Z'graggen K; Centeno BA; Fernandez-del Castillo C; Jimenez RE; Werner J; Warshaw AL
    Surgery; 2001 May; 129(5):537-46. PubMed ID: 11331445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastasis of pancreatic tumors].
    Häberle L; Braren R; Schlitter AM; Esposito I
    Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
    Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
    Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
    Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.
    Manjunath Y; Porciani D; Mitchem JB; Suvilesh KN; Avella DM; Kimchi ET; Staveley-O'Carroll KF; Burke DH; Li G; Kaifi JT
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma.
    Yan J; Chen G; Zhao X; Chen F; Wang T; Miao F
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1908-1914. PubMed ID: 29242154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.
    Powell AE; Anderson EC; Davies PS; Silk AD; Pelz C; Impey S; Wong MH
    Cancer Res; 2011 Feb; 71(4):1497-505. PubMed ID: 21303980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
    Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
    Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.